Synovus Financial Corp Axogen, Inc. Transaction History

Synovus Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$10.62 - $13.12 $84 - $104	-8 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$7.35 - $10.81 $4,108 - $6,042	-559 Reduced 98.59%	8 $0
Q1 2020 Apr 24, 2020	SELL	$8.38 - $17.34 $54,084 - $111,912	-6,454 Reduced 91.92%	567 $7,000
Q4 2019 Feb 06, 2020	BUY	$11.18 - $18.6 $8,183 - $13,615	732 Added 11.64%	7,021 $116,000
Q3 2019 Nov 01, 2019	BUY	$12.09 - $20.46 $76,034 - $128,672	6,289 New	6,289 $66,000

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.